Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01ORM
|
||||
Former ID |
DIB001950
|
||||
Drug Name |
Mitonafide
|
||||
Synonyms |
Mitonafide < Rec INN >; N-[2-(Dimethylamino)ethyl]-3-nitronaphthalimide; 2-[2-(Dimethylamino)ethyl]-5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 2 | [545276] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H15N3O4
|
||||
Canonical SMILES |
CN(C)CCN1C(=O)c2cccc3cc(cc(C1=O)c23)[N+](=O)[O-]
|
||||
InChI |
1S/C16H15N3O4/c1-17(2)6-7-18-15(20)12-5-3-4-10-8-11(19(22)23)9-13(14(10)12)16(18)21/h3-5,8-9H,6-7H2,1-2H3
|
||||
InChIKey |
XXVLKDRPHSFIIB-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 54824-17-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA topoisomerase II | Target Info | Modulator | [534235] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.